All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma

Laryngoscope

Volumn 111, Issue 8, 2001, Pages 1459-1464

  Nakashima, Torahiko ^a,b,c   Sun, Shi Yong ^a   Lotan, Reuben ^a   Fujiwara, Toshiyoshi ^b   Yasumatsu, Ryuji ^c   Komiyama, Sohtaro ^c   Clayman, Gary L ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

CMV promoter; Gene therapy; p53; Retinoid

Indexed keywords

GENE PRODUCT; GREEN FLUORESCENT PROTEIN; PROTEIN BAX; PROTEIN P21; PROTEIN P53; RETINOIC ACID;

ADENOVIRUS; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG POTENTIATION; GENE THERAPY; GENE TRANSFER; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0034903213     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200108000-00024     Document Type: Article

References (37)

1. The p53 tumor suppressor gene
2. Frequent p53 mutations in head and neck cancer
3. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers
4. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer
5. A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours
6. Adenovirus vectors for gene delivery
7. Polycations and cationic lipids enhance adenovirus transduction and transgene expression in tumor cells
8. Use of protamine to augment adenovirus-mediated cancer gene therapy
9. Modification of an adenoviral vector with biologically selected peptides: A novel strategy for gene delivery to cells of choice
10. Retargeting to EGFR enhances adenovirus infection efficiency of squamous cell carcinoma
11. Targeting adenovirus
12. Recent advances in chemoprevention of cancer
13. Molecular epidemiology and retinoid chemoprevention of head and neck cancer
14. Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression
15. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract
16. Vitamin A and regulation of gene expression
17. Retinoids and chemoprevention of aerodigestive tract cancers
18. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus
19. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus
20. Induction of apoptosis in maxillary sinus cancer cells by 5-fluorouracil, vitamin A and radiation (FAR) therapy
21. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death
22. Gene therapy for head and neck cancer. Comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21)
23. Green fluorescent protein as a marker for gene expression
24. Interactions of retinoid binding proteins and enzymes in retinoid metabolism
25. Retinoic acid and thyroid hormone induce gene expression through a common responsive element
26. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia
27. Retinoic acid receptors initiate induction of the cytomegalovirus enhancer in embryonal cells
28. Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells
29. Transcriptional regulation of the human cytomegalovirus major immediate-early gene is associated with induction of DNase I-hypersensitive sites
30. Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids
31. Retinoic acid modulates a bimodal effect on cell cycle progression in human adult T-cell leukemia cells
32. Suppression of squamous cell carcinoma growth and differentiation by retinoids
33. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis
34. Tumor suppressor p53 is a direct transcriptional activator of the human BAX gene
35. Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy
36. The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer
37. Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neck